E. Gregory MacEwen

8.1k total citations · 1 hit paper
113 papers, 6.1k citations indexed

About

E. Gregory MacEwen is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Immunology. According to data from OpenAlex, E. Gregory MacEwen has authored 113 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 51 papers in Genetics and 26 papers in Immunology. Recurrent topics in E. Gregory MacEwen's work include Veterinary Oncology Research (62 papers), Virus-based gene therapy research (49 papers) and Cancer Research and Treatments (16 papers). E. Gregory MacEwen is often cited by papers focused on Veterinary Oncology Research (62 papers), Virus-based gene therapy research (49 papers) and Cancer Research and Treatments (16 papers). E. Gregory MacEwen collaborates with scholars based in United States, Netherlands and Cyprus. E. Gregory MacEwen's co-authors include David M. Vail, Ilene D. Kurzman, Stephen J. Withrow, A. K. Patnaik, William J. Ehler, Amiya K. Patnaik, Robert Rosenthal, Nancy O. Brown, Audrey A. Hayes and Robert E. Matus and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

E. Gregory MacEwen

109 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 Dogs

1984 591 citations A. K. Patnaik, E. Gregory MacEwen et al. Veterinary Pathology profile →

Peers

Countries citing papers authored by E. Gregory MacEwen

Since Specialization

Citations

This map shows the geographic impact of E. Gregory MacEwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gregory MacEwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gregory MacEwen more than expected).

Fields of papers citing papers by E. Gregory MacEwen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Gregory MacEwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gregory MacEwen. The network helps show where E. Gregory MacEwen may publish in the future.

Co-authorship network of co-authors of E. Gregory MacEwen

This figure shows the co-authorship network connecting the top 25 collaborators of E. Gregory MacEwen. A scholar is included among the top collaborators of E. Gregory MacEwen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gregory MacEwen. E. Gregory MacEwen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vitro effects of 2‐methoxyestradiol on canine tumour cells 2003 ·Veterinary and Comparative Oncology ·(unknown), Douglas H. Thamm, Ilene D. Kurzman, David M. Vail, E. Gregory MacEwen	2
2	Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer 2000 ·Cancer Investigation ·David M. Vail, E. Gregory MacEwen	385
3	In Vitro and In Vivo Enhancement of Canine Pulmonary Alveolar Macrophage Cytotoxic Activity Against Canine Osteosarcoma Cells 1999 ·Cancer Biotherapy and Radiopharmaceuticals ·Ilene D. Kurzman, Fushun Shi, David M. Vail, E. Gregory MacEwen	39
4	AN ACCELERATED TECHNIQUE FOR IRRADIATION OF MALIGNANT CANINE NASAL AND PARANASAL SINUS TUMORS 1998 ·Veterinary Radiology & Ultrasound ·William M. Adams, Paul E. Miller, David M. Vail, Lisa J. Forrest, E. Gregory MacEwen	75
5	Amputation and Carboplatin for Treatment of Dogs With Osteosarcoma: 48 Cases (1991 to 1993) 1996 ·Journal of Veterinary Internal Medicine ·Philip J. Bergman, E. Gregory MacEwen, Ilene D. Kurzman, Carolyn J. Henry, Alan S. Hammer, Deborah W. Knapp, Ann Hale, Stephen A. Kruth, Mary K. Klein, Jeffrey S. Klausner, Alan Norris, Dudley L. McCaw, Rodney C. Straw, Stephen J. Withrow	177
6	Prognostic factors for treatment of malignant lymphoma in dogs 1994 ·Journal of the American Veterinary Medical Association ·Erik Teske, P. van Heerde, Gerard R. Rutteman, Ilene D. Kurzman, Peter F. Moore, E. Gregory MacEwen	142
7	Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a model 1993 ·Cancer Chemotherapy and Pharmacology ·David M. Vail, Adnan A. Elfarra, A. James Cooley, David L. Panciera, E. Gregory MacEwen, Steve A. Soergel	12
8	In vitro and in vivo canine mononuclear cell production of tumor necrosis factor induced by muramyl peptides and lipopolysaccharide 1993 ·Veterinary Immunology and Immunopathology ·Ilene D. Kurzman, Fushun Shi, E. Gregory MacEwen	19
9	Evaluation of Prognostic Factors and Sequential Combination Chemotherapy With Doxorubicin for Canine Lymphoma 1993 ·Journal of Veterinary Internal Medicine ·Evan T. Keller, E. Gregory MacEwen, Robert Rosenthal, Stuart C. Helfand, Leslie E. Fox	179
10	Plasma Histamine and Gastrin Concentrations in 17 Dogs With Mast Cell Tumors 1990 ·Journal of Veterinary Internal Medicine ·Leslie E. Fox, Robert Rosenthal, David C. Twedt, Richard R. Dubielzig, E. Gregory MacEwen, Gregory F. Grauer	37
11	A Clinicopathologic and Ultrastructural Study of Undifferentiated Malignant Tumors of the Oral Cavity in Dogs 1986 ·Veterinary Pathology ·A. K. Patnaik, Philip Lieberman, Robert A. Erlandson, E. Gregory MacEwen, Arthur I. Hurvitz	3
12	Extramedullary plasmacytoma of the gastrointestinal tract in two dogs 1984 ·Journal of the American Veterinary Medical Association ·E. Gregory MacEwen, A. K. Patnaik, Gerald Johnson, Arthur I. Hurvitz	16
13	Combined modality therapy in the treatment of solid tumors in cats. 1980 ·Journal of the American Animal Hospital Association ·(unknown), Audrey A. Hayes, Samantha Mooney, A. K. Patnaik, Hugh Harvey, E. Gregory MacEwen	7
14	Chemotherapeutic Management of Transmissible Venereal Tumors in 30 Dogs 1980 ·Journal of the American Veterinary Medical Association ·Nancy O. Brown, Clay A. Calvert, E. Gregory MacEwen	21
15	Cutaneous lymphosarcoma in the dog: a disease with variable clinical and histologic manifestations. 1980 ·Journal of the American Animal Hospital Association ·(unknown), (unknown), A. K. Patnaik, E. Gregory MacEwen	22
16	Feline systemic mastocytosis: a review and results of splenectomy in seven cases 1979 ·Journal of the American Animal Hospital Association ·William D. Liska, E. Gregory MacEwen, (unknown), M T Garvey	24
17	Soft Tissue Sarcomas in the Cat 1978 ·Journal of the American Veterinary Medical Association ·Nancy O. Brown, Amiya K. Patnaik, Samantha Mooney, Audrey A. Hayes, Hugh Harvey, E. Gregory MacEwen	29
18	Hyperviscosity Syndrome Associated with Lymphocytic Leukemia in Three Dogs 1977 ·Journal of the American Veterinary Medical Association ·E. Gregory MacEwen, Arthur I. Hurvitz, Audrey A. Hayes	12
19	Neurotoxicosis Associated with Use of 5-Fluorouracil in Five Dogs and One Cat 1977 ·Journal of the American Veterinary Medical Association ·Hugh Harvey, E. Gregory MacEwen, Audrey A. Hayes	13
20	Treatment of Basophilic Leukemia in a Dog 1975 ·Journal of the American Veterinary Medical Association ·E. Gregory MacEwen, (unknown), A. J. McClelland, Robert J. Wilkins	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact